RxDoctor Payments DataLook up a doctor →

Yusuf Deshmukh, MD

Hematology & Oncology · Elizabethtown, KYNPI 1972585883

Payments from drug & device makers

$16,231in general payments, 2019–2025

Across 881 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • AstraZeneca$2K
  • Johnson & Johnson$877
  • Pfizer$865
  • Takeda Pharmaceuticals U.S.A., Inc.$724
  • Eisai Inc.$674
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis115$1,637
AstraZeneca(2 entities)78$1,561
Johnson & Johnson54$877
Pfizer60$865
Takeda Pharmaceuticals U.S.A., Inc.35$724
Eisai Inc.37$674
Seagen Inc.34$670
Daiichi Sankyo Inc.27$660
Lilly USA, LLC26$505
Amgen23$433
Bristol Myers Squibb20$425
Incyte Corporation18$420
Rigel Pharmaceuticals, Inc.15$412
Pharmacyclics LLC, An Abbvie Company23$375
AbbVie19$362
Gilead(2 entities)17$297
Beigene USA, Inc.16$295
Astellas Pharma US Inc8$283
Merck15$254
Ipsen Biopharmaceuticals, Inc13$254
Pharmaessentia USA Corporation13$242
Puma Biotechnology, Inc.11$238
Clovis Oncology, Inc.14$210
Regeneron Healthcare Solutions, Inc.9$203
E.r. Squibb & Sons, L.L.C.9$177
Boehringer Ingelheim11$177
Taiho Oncology, Inc.9$169
Sanofi8$148
Tersera Therapeutics LLC6$145
Array Biopharma Inc11$140
Bayer10$139
Acrotech Biopharma Inc.7$126
Genentech USA, Inc.6$122
Global Blood Therapeutics, Inc.6$100
Kyowa Kirin, Inc.5$93
EMD Serono, Inc.4$92
Sobi, Inc4$91
Blueprint Medicines Corporation4$89
Karyopharm Therapeutics Inc.5$89
G1 Therapeutics, Inc.5$78
Beone Medicines USA, Inc.4$72
ADC Therapeutics America, Inc.4$69
Apellis Pharmaceuticals, Inc.3$65
Stemline Therapeutics Inc.3$65
Genmab U.S., Inc.3$63
Pharmacosmos Therapeutics Inc.3$61
Aurobindo Pharma USA, Inc.3$55
Teva Pharmaceuticals USA, Inc.3$53
Dova Pharmaceuticals3$50
Octapharma USA, Inc.2$49
Syndax Pharmaceuticals, Inc.2$48
Shield Therapeutics Inc3$48
Sun Pharmaceutical Industries Inc.2$42
Iovance Biotherapeutics, Inc.1$39
TG Therapeutics, Inc.2$39
Morphosys, US Inc.2$36
Geron Corporation1$34
Azurity Pharmaceuticals, Inc.2$29
Tempus AI, Inc1$27
Secura Bio, Inc.1$25

How this compares

$16,231 in reported general payments places this provider in the 55th percentile of 143 hematology & oncology providers in Kentucky.

See all hematology & oncology providers in Kentucky →

Medicare billing

Part B allowed, 2024
$1,958,081
Medicare patients
486
Services billed
65,803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Elizabethtown

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →